New Zealand markets open in 2 hours 8 minutes

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7914-0.0378 (-4.56%)
As of 03:52PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.8292
Bid0.7830 x 1000
Ask0.7860 x 1100
Day's range0.7800 - 0.8697
52-week range0.7000 - 7.2400
Avg. volume12,586,930
Market cap113.866M
Beta (5Y monthly)1.67
PE ratio (TTM)N/A
EPS (TTM)-2.2900
Earnings date02 Aug 2022 - 08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.00
  • Motley Fool

    2 Biotech Stocks That Could Go Parabolic

    Biotech stocks have taken a beating to start the year, with the S&P Biotech Industry Index down more than 49% so far. There are several reasons a biotech stock could go parabolic -- that is, have its shares see a sharp rise in a short period. The company could be the buyout target of a merger deal with a larger pharmaceutical company.

  • Zacks

    Alcon (ALC) to Report Q1 Earnings: What's in the Cards?

    Strength in Vision Care with the addition of new products and recent acquisition is likely to have contributed to Alcon's (ALC) first-quarter performance.

  • Zacks

    Endo (ENDP) Beats on Q1 Earnings, Guides Weak Q2 Results

    Endo (ENDP) tops Q1 earnings and sales estimates. However, Vasostrict faces generic competition and the guidance for Q2 is dismal.